Article Details

Structure of the Pharmaceutical Industries in India | Original Article

Amit Rajendra Jaiswal*, Naveen Kumar Singhal, in Journal of Advances and Scholarly Researches in Allied Education | Multidisciplinary Academic Research


The health status of every nation is directly related to its ability to prevent, treat, and promote disease. Nevertheless, the pharmaceutical industry's expansion is important to implementing these steps with available qualified people resources and infrastructure. Health professionals, health infrastructure, medical invention and innovation, and the form of government programmes and regulations all have a role in health status. Pharma Vision 2020, a plan to make India the world's leading producer of end-to-end pharmaceuticals, was unveiled by the Indian government. To encourage more investment, the approval process for new facilities has been sped up. To address this problem, the government has implemented measures such as the Drug Price Control Order and the National Pharmaceutical Pricing Authority ( The manufacturing costs in India are much cheaper than those in the United States and Europe. It offers India an advantage in the competition. (Sectoral Report September 2016)... The rivalry in these marketplaces is critical to the production of high-quality pharmaceuticals at reasonable rates for customers. Anti-competitive practises in the industry must be addressed, and the rule of law plays a critical role in ensuring that markets remain competitive. To this end, the researcher sought to assess the current state of the Indian pharmaceutical market's organisation and laws, as well as the prevalence of anti-competitive practises. The market becomes less competitive when there is too much regulation. Human society's out-of-pocket costs for pharmaceutical items may be reduced by an equal act of management and competition.